Fig. 4. Cellular anti-proliferation (MTT) curves showing the response of LNCaP (PSMA +ve) cells to treatment with (A) GNF-2, (B) GNF-3, and (C) GNF-4. In each plot, the black data points correspond to treatment of the LNCaP cells with the native (non-functionalised) GNF in the same formulation as the active compounds.
